Singapore markets close in 7 hours 54 minutes

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6096+0.0085 (+1.41%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.86M
Enterprise value 5.06M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.00
Price/book (mrq)1.12
Enterprise value/revenue 0.52
Enterprise value/EBITDA -2.04

Trading information

Stock price history

Beta (5Y monthly) 1.95
52-week change 387.20%
S&P500 52-week change 323.57%
52-week high 39.4900
52-week low 30.0800
50-day moving average 30.6922
200-day moving average 30.8753

Share statistics

Avg vol (3-month) 31.6M
Avg vol (10-day) 3472.97k
Shares outstanding 517.67M
Implied shares outstanding 617.67M
Float 89.96M
% held by insiders 164.38%
% held by institutions 10.59%
Shares short (15 Apr 2024) 499.74k
Short ratio (15 Apr 2024) 41.15
Short % of float (15 Apr 2024) 40.58%
Short % of shares outstanding (15 Apr 2024) 40.56%
Shares short (prior month 15 Mar 2024) 420.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -26.91%
Operating margin (ttm)7.36%

Management effectiveness

Return on assets (ttm)-12.68%
Return on equity (ttm)-32.21%

Income statement

Revenue (ttm)9.77M
Revenue per share (ttm)0.62
Quarterly revenue growth (yoy)-20.00%
Gross profit (ttm)N/A
EBITDA -1.96M
Net income avi to common (ttm)-2.63M
Diluted EPS (ttm)-0.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.93M
Total cash per share (mrq)0.34
Total debt (mrq)146.59k
Total debt/equity (mrq)1.52%
Current ratio (mrq)4.93
Book value per share (mrq)0.55

Cash flow statement

Operating cash flow (ttm)-1.3M
Levered free cash flow (ttm)566.75k